Clinical trial
Assessment of HyperQ Signal for Detecting Ischemia During Dobutamine Stress ECG
NCT00310622 · BSP Biological Signal Processing Ltd., Industry · Unknown status
Key facts
| NCT number | NCT00310622 |
|---|---|
| Title | Assessment of HyperQ Signal for Detecting Ischemia During Dobutamine Stress ECG |
| Official title | An Assessment of the HyperQ Signal for Detecting Ischemia During Dobutamine Stress Echocardiography (DSE) |
| Lead sponsor | BSP Biological Signal Processing Ltd., Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myocardial Ischemia |
| Intervention type | Device |
| Interventions | HyperQ Signal recording |
| Enrollment | 150 |
| Start date | Mar 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Apr 4, 2006 |
| Last update posted | Mar 1, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: